ICU admission for solid cancer patients treated with immune checkpoint inhibitors.
Anne-Claire ToffartAnne-Pascale MeertFlorent WalletAude GibelinOlivier GuissetFrédéric GonzalezAmélie SeguinAchille KouatchetMyriam DelaunayDidier DebieuvreBoris DuchemannGaëlle Rousseau-BussacMartine NyungaDavid GrimaldiAlbrice LevratElie AzoulayVirginie LemialePublished in: Annals of intensive care (2023)
IrAEs accounted for half of ICU admissions in cancer patients receiving ICIs. They could be treated with steroids. Identifying the imputability of irAEs in ICU admissions remains a challenge.